United States News All stories

First Majestic Silver (NYSE:G) reported on April 9, 2026, that consolidated ore processed at its Mexican operations rose 12% year-over-year to 1,059,333 tonnes in the first quarter.

Neogen (NASDAQ:NEOG), a global leader in food and animal safety, reported on April 9, 2026, that it has raised its full-year revenue guidance following a third-quarter performance marked by steady gains in its core food safety business and significant progress on strategic portfolio realignments.

Polestar (NASDAQ:PSNY), the Swedish electric performance car manufacturer, reported on April 9, 2026, that estimated retail sales for the first quarter reached 13,126 vehicles.

BlackBerry (NYSE:BB) reported its fiscal fourth-quarter and full-year 2026 financial results on April 9, 2026, highlighting a significant turnaround in profitability driven by record demand for its automotive and embedded software division.

The Buckle (NYSE:BKE) announced on April 9, 2026, a robust performance for the five-week fiscal month ended April 4, 2026, with net sales climbing 8.2% to $118 million.

Eli Lilly and Company (NYSE:LLY) achieved a significant milestone in the competitive metabolic health market as its once-daily oral medication, Foundayo (orforglipron), became available in U.S. retail pharmacies on April 9, 2026.

IDEAYA Biosciences (NASDAQ:IDYA), a precision medicine oncology company, announced on April 9, 2026, that it has entered into a clinical collaboration agreement with AstraZeneca (NASDAQ:AZN) to study a potential first-in-class combination treatment for extensive-stage small cell lung cancer (SCLC).

Prologis (NYSE:PLD), the global leader in logistics real estate, and La Caisse de dépôt et placement du Québec (CDPQ) announced on April 9, 2026, the launch of Prologis Logistics Investment Venture Europe (PLIVE).

Whitestone REIT (NYSE:WSR) announced on April 9, 2026, that it has entered into a definitive merger agreement to be acquired by funds managed by Ares Real Estate in an all-cash deal valued at approximately $1.7 billion, including the assumption of debt.

Natera (NASDAQ:NTRA), a pioneer in cell-free DNA (cfDNA) testing, announced on April 9, 2026, that the United States District Court for the District of Delaware has issued a favorable ruling regarding its ongoing patent litigation against ArcherDx and Invitae.

Oppenheimer (NYSE:OPY) announced on April 9, 2026, that David Fleming has been promoted to a senior leadership position within the firm’s Private Client Division.

Fortuna Mining (NYSE:FSM) reported on April 9, 2026, that its gold equivalent production rose to 72,872 ounces (GEO) in the first quarter of 2026, representing a significant increase from the 65,130 GEO produced in the final quarter of 2025.

Hutchmed (NASDAQ:HCM) announced on April 9, 2026, that it will present a series of new preclinical and clinical datasets at the American Association for Cancer Research (AACR) Annual Meeting.

Magna International (NYSE:MGA), one of the world’s largest automotive suppliers, announced on April 9, 2026, that it has signed definitive agreements to divest its Lighting and Rooftop Systems businesses.

111 (NASDAQ:YI), a leading tech-enabled healthcare platform in China, reported its unaudited financial results for the fourth quarter and full fiscal year ended December 31, 2025, on April 9, 2026.

Tehran officially closes the Strait of Hormuz following the violations of the April 8 ceasefire.

Evotec (NASDAQ:EVO) reported strong financial results for the fourth quarter and full-year 2025 on April 8, 2026, delivering performance at the high end of its guidance and signaling the start of a major operational transformation under its new "Horizon" model.

Beasley Broadcast Group (NASDAQ:BBGI) reported a significant net loss for the fourth quarter of 2025, driven primarily by a substantial non-cash impairment charge, while simultaneously detailing a strategic debt exchange intended to halve the company’s total liabilities.

ANI Pharmaceuticals (NASDAQ:ANIP) announced on April 8, 2026, that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Isosorbide Mononitrate Tablets USP, 10 mg and 20 mg.

Delta Air Lines (NYSE:DAL) reported record adjusted revenue for the first quarter of 2026, as robust international demand and a recovery in corporate travel offset rising operational costs and geopolitical headwinds.

The era of "AI augmentation" — that polite corporate fiction where software was merely a "co-pilot" designed to help humans work faster — has ended. 

In its place, 2026 has ushered in a period of cold, clinical replacement. 

For decades, the global transition to renewable energy was a project of incrementalism — a slow-moving mosaic of carbon taxes, solar subsidies, and earnest international accords that often felt more aspirational than urgent. 

Policy wonks argued over the nuances of the Inflation Reduction Act, while climate activists lamented the glacial pace of the "energy pivot."

For the better part of a decade, the gilded youth of the financial world — the "crypto-native" generation — dismissed gold as a "boomer rock." 

To them, the heavy, yellow metal was an analog relic, a petrous souvenir of an era before the lightning-fast efficiency of the blockchain. 

For years, the global defence industry existed in a sort of polite exile. 

In the era of ESG mandates and the "peace dividend," shares in weapons manufacturers were often treated as the "tobacco stocks" of the new millennium — profitable, perhaps, but unseemly.